The health and fitness market is saturated with training methods, supplements and recovery tools that make bold claims but lack supporting research and validation which often results in confusion, wasted time/money and frustration for consumers when they do not achieve the intended benefit. If validation studies are available, it is often crude research performed by a paid company (intrinsic bias) on a small population & over a short duration of time, thereby limiting the power to extrapolate these outcomes to a large population.

At NeuroForce1, we perform in-house validation studies for every tool, supplement or intervention that we utilize in our data-driven protocols or product distribution offering. We do not simply assess for instantaneous improvements, but continue to assess lasting impact (benefits & ill effects) on highly specific populations.

All assessments utilized in the NF1 lab are clinical-grade & non-invasive (no blood or physical manipulation), including:

The primary goal of the NF1 Lab is to gather real data from real people participating in real life. The metrics utilized to assess parameters including sleep efficiency, recovery, stress and overall performance are only as valuable as the reliability of the data collection, construct validity of the study itself and how the data is analyzed for statistical significance.

All NF1 validation studies are performed utilizing clinical-grade equipment under the guidance of a qualified/certified professional and in a natural setting that limits confounds associated with clinical data collection (white coat syndrome, clinical sleep analysis, etc.). While many of our studies do involve a placebo or control group, we believe the greatest significance is delivered by comparing an individual’s baseline/pre-intervention data to objective & quantifiable improvements over time.

Utilizing the NF1 Biostrap, the first clinically validated wearable technology, in addition to clinical grade assessment technology at the NF1 Lab, we are able to provide unique reliable data collection methods to individuals without geographical limitation.

A primary differentiator of our data collection methods is the emphasis on establishing a baseline for each participant for a minimum of 5-days prior to intervention. After establishing reliable data trends (with covariance taken into account), we are able to objectively assess and quantify improvements based on any intervention or combination of interventions for synergistic effect analysis, as well as continue to assess lasting benefit post-intervention.

Essentially, the individual’s baseline represents the control group to avoid assumption-based analysis techniques such as group matching and truly understand physiological changes at an individualized level.